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Background/Purpose: The fractions were tested to investigate their chemical composition and antifungal
potential in vitro.
Methods/Results: The results obtained through the chromatographic analysis allowed the identification of 28
compounds. Microbiological assays were carried out in order to determine the IC50, cell viability curve and
inhibitory effect of the association of the fractions with Fluconazole (FCZ), against Candida spp. through the
microdilution methodology. The assays for verification of change in morphology and Minimal Fungicidal
Concentration were performed in solid media. The IC50 of the isolated and associated fractions were calcu-
lated to be between 5.10 and 926.56 mg/mL, when associated with FCZ the concentrations were reduced to
512 mg/mL and 1024 mg/mL, the IC50 value of the fractions associated with fluconazole varied between 1.38
and 925.56mg/mL.
Conclusions: The fractions affect the morphological transition and have a relevant antifungal potential, as
they caused fungal inhibition in isolated use and potentiated the action of FCZ.
© 2020 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
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The pathologies caused by fungi today are among the most com-
plicated diseases to be controlled in humans. Some fungi cause ill-
nesses in people without health problems, however most mycoses
affect patients who already have a serious illness and often hamper
the success of the latest medical advances in cancer treatment, solid
organ and hematopoietic cell transplantations, neonatal drugs, auto-
immune diseases, trauma and intensive care, as well as sophisticated
surgeries (K€ohler et al., 2015).Among species from the Candida genus, Candida albicans is the
main strain responsible for diseases that may affect the skin or
mucosa (Lopez-Martinez, 2010) or which may enter the bloodstream
and dissipate into internal organs (Calderone e Fonzi, 2001). Other
emerging non-albicans species such as C. dubliniensis, C. glabrata, C.
tropicalis and C. krusei were also associated with invasive candidiasis
(Miceli, Diaz e Lee, 2011).
Candidiasis is the most prevalent fungal pathology affecting
humans and the focus of the problem is that it is associated with a
1049% mortality rate in immunocompromised patients (Pfaller e
Diekema, 2007).
Resistance to current antifungal drugs has become a clash and the
clinical efficacy of these drugs has been threatened by the emergence
of multi-drug resistant species (Paul e Moye-Rowley, 2014). Azoles
are the first-line antifungal drugs for the treatment of candidiasis
(Chen et al., 2008).
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the normal human microbiota and can be isolated in the most diverse
anatomical sites; in the mouth, for example, around 20 to 50% of healthy
teeth are colonized by Candida spp. (Zomorodian et al., 2011).
The Psidium genus has a number of proven biological activities
both in vitro and in vivo including an antifungal effect (Suwanmanee;
Kitisin; Luplertlop, 2014; Wen et al., 2011). Among the species from
this genus, Psidium guajava L. has ethnomedicinal value where it is
known for its therapeutic versatility, being used among other things
for the treatment of symptoms associated with infections caused by
Candida spp. (Morais-Braga et al., 2015, 2016).
Natural products originating from plant are reported to be a rich
source of diverse compounds that may serve as the basis for the ratio-
nal drug model (Ksouri et al; Zida et al., 2017).
Research has been carried out to promote the combination of
commercial drugs, for which the resistance phenomenon has already
been verified, with natural products in the form of extracts, fractions,
essential oils or isolated constituents in an attempt to circumvent
Candida spp. Resistance (Calixto Junior et al., 2015).
Researchers are increasingly turning their attention to the study
of natural products, seeking the development of safer, less toxic drugs
with a reduced rate of side effects and ready to overcome the antifun-
gal resistance threat. The objective of this study was to investigate
the chemical composition and the in vitro effects of fractions from
fresh P. guajava L. leaves in isolation, combined with both each other
and with fluconazole, in the inhibition of fungal growth and inhibi-
tion of the Candida spp. virulence factor.2. Methodology
2.1. Collection area
The plant material was collected in a rural area in the Crato
municipality, south of Ceara, Brazil (425 m, 07,140,1800 south latitude
and 39,230,3700 west longitude of Greenwich). The collection period
was between 8:30 a.m. and 10:30 a.m. in the month of March/2017.
From the material collected, an exsiccate was produced and subse-
quently deposited in the Caririense Dardano de Andrade-Lima Her-
barium (HCDAL) of the Regional University of Cariri - URCA,
identified and registered under number 13.222.2.2. Plant material and
The study was carried out using young and healthy Psidium gua-
java L. leaves, locally known as guava, without any indication ofTable 1
UPLC-ESI-QTOF-MS- identification of chemical constituents of the Fresh Leaf Flavonoid Frac
Peak
no.
Rt min [M-H]-
Observed
[M-H]-
Calculated
Product Ions (MS/MS) Empiri
Formu
1 0.98 481,0619 481,0618 300,9985, 275,0188, C20H17
2 1.865 169,0134 169,0137 125,0261 C7H5O
3 2.421 305,0668 305,0661 219,0637, 125,0252, C15H13
4 3.197 289,0708 289,0712 245,0794, 203,0695, 125,0243, C15H14
5 4.08 615,0989 615,0986 463,0887, 300,0231 C28H23
6 4.292 300,9936 300,9984 229,0529 C14H6O
7 4.665 433,0745 433,0771 301,0316 C20H18
8 5.557 571,1429 571,1452 313,0545, 257,0827, 169,0134 C28H27
9 6.889 327,2157 327,2171 328,2348 C18H31
10 7.860 501,3207 501,3216 473,2345, 301,0359, 269,0527 C30H45
11 9.839 271,0590 271,0606 ___ C15H11
12 12.138 491,2369 491,2375 ___ C37H31
13 14.010 489,2210 489,2218 ___ C37H29
The compounds were tentatively identified according to mass spectra and corresponding
Observed: Mass observed in experiment, [MH] - Calculated: Mass calculated by software, Prcontamination by parasites. Fresh leaves, which were later crushed
into small pieces, were used to obtain the fractions. The extraction of
the tannic and flavonoid fractions and the chemical characterization
by UPLC-QTOF were performed as described by Bezerra et al. (2018).2.3. Antifungal assays and statistical analysis
The antifungal assays were performed as reported previously
(Bezerra et al., 2018). The data obtained were checked for their nor-
mal distribution and then analyzed by a two-way ANOVA (P <0.05;
* P <0.1; **** P <0.0001), comparing the values for each concentration
of the extract, point by point, with Bonferroni's post hoc test. The IC50
values were obtained by non-linear regression with interpolation of
standard curve unknowns obtained from fungal growth as a function
of extract concentration and expressed in mg/mL. For the statistical
analysis, the software Graphpad Prism, v. 5.0 was used.3. Results
3.1. Identification of chemical constituents- UPLC-ESI-QTOF-MS
The identification of the compounds was performed based on the
data provided by the program used, such as its retention times, mass
spectra, along with the information previously mentioned in the lit-
erature. Tables 1 and 2 summarize the identification information:
retention times, mass (m/z) of the experiment and calculated, frag-
ments (MS/MS), molecular formula and error (ppm).
From the chemical analyzes of the fractions, we can observe in
Table 1 the results from the Flavonoid Fraction of Fresh P. guajava
L. Leaves where 13 compounds were found, of which three were
flavonoids (Quercetin-galloylhexoside Isomer, Reynoutrin and
Narigerina), four hydrolysable tannins (HHDP glucose Isomer 1,
gallic acid, ellagic acid and Guavinoside B), two condensed tan-
nins (Galocatechin and Catechin), an alkaloid (9(S),12(S),13(S)-Tri-
hydroxy-10 E),15(Z)-octadecadienoic acid), the other compounds
could not be identified.
In Table 2 we have the chemical composition of the Tannic Frac-
tion from Fresh P. guajava L. Leaves where 15 compounds were
found, of which eight were possible to be identified: four flavonoids
(Procyanidin B isomer, Quercetin, Reynoutrin (Quercetin-3D-O-xylo-
side) and 2,6-dihydroxy-3-methyl-4-O-(600-O-galloyl-b-D-glucopyra-
nosyl)-benzophenone), two condensed tannins (Galocatechin and
Galocatechin isomer) and two hydrolysable tannins (ellagic acid and
Guavinoside B), predominantly in the two fractions the presence of
phenolic compounds.tion of Psidium guajava (A).
cal
la
Ppm
(error)
Putative Name Refere^ncias
O14 0.2 HHDP glucose Isomer 1 (Díaz-de-Cerio et al., 2016)
5 1.8 Gallic acid (Díaz-de-Cerio et al., 2016)
O7 2.3 Galocatechin (Díaz-de-Cerio et al., 2016)
O6 1.4 Catechin (Díaz-de-Cerio et al., 2016)
O16 0.5 Quercetin-galloylhexoside Isomer (Díaz-de-Cerio et al., 2016)
8 2.0 Ellagic acid (Díaz-de-Cerio et al., 2016)
O11 6.0 Reynoutrin (Díaz-de-Cerio et al., 2016)
O13 4.0 Guavinoside B (Díaz-de-Cerio et al., 2016)
O5 4.3 9(S),12(S),13(S)-Trihydroxy-10 (E),
15(Z)-octadecadienoic acid
(Cao et al., 2014)
O6 1.8 Not identified
O5 5.9 Naringenin (Díaz-de-Cerio et al., 2016)
O 1.2 Not identified
O 1.6 Not identified
literature data. Peak no .: Peak number, Rt min: Retention time in minutes, [MH] -
oduct Ions: Ionic product, Ppm:, Putative name : Possible name.
Table 2
UPLC-ESI-QTOF-MS- identification of chemical constituents of the Fresh Leaves Tannic Fraction of Psidium guajava (B).
Peak
no.
Rt min [M-H]-
Observed
[M-H]-
Calculated
Product Ions (MS/MS) Empirical
Formula
Ppm
(error)
Putative Name Refere^ncias
1 2.430 305,0648 305,0661 219,0654, 125,0249 C15H13O7 4.3 Gallocatechin (Díaz-de-Cerio et al., 2016)
2 2.877 577,1357 577,1346 425,0906, 407,0778,
289,0704, 125,0241
C30H25O12 1.9 Procyanidin B Isomer (Díaz-de-Cerio et al., 2016)
3 3.205 289,0642 289,0653 245,0822 C22H9O 3.8 Not identified
4 3.645 305,0674 305,0661 125,0254 C15H14O7 4.3 Gllocatechin isomer (Díaz-de-Cerio et al., 2016)
5 4.292 300,9954 300,9984 229,0248 C14H6O8 10 Ellagic acid (Díaz-de-Cerio et al., 2016)
6 4.387 301,0354 301,0348 178,9975, 151,0005 C15H10O7 2.0 Quercetin (Díaz-de-Cerio et al., 2016)
7 4.657 433,0763 433,0771 301,0292 C20H18O11 1.8 Reynoutrin (Quercetin- 3D-O-xilosideo) (Díaz-de-Cerio et al., 2016)
8 5.558 571,1442 571,1452 313,0542, 257,0785,
169,0122
C28H28O13 1.8 Guavinoside B (Díaz-de-Cerio et al., 2016)
9 6.005 557,1273 557,1295 313,0570, 243,0655,
169,0142
C27H26O13 3.9 2,6-dihydroxy-3-methyl-4- O-
(600-O-galloyl-b-D- glucopyranosyl)-
benzophenone
(Díaz-de-Cerio et al., 2016)
10 7.860 501,3194 501,3216 ___ C30H46O6 4.4 Not identified
11 8.400 503,3365 503,3373 ___ C30H48O6 1.6 Not identified
12 10.935 633,3801 633,3791 ___ C39H54O7 1.6 Not identified
13 12.175 491,2419 491,2434 ___ C30H36O6 3.1 Not identified
14 14.063 489,2255 489,2277 ___ C30H34O6 4.5 Not identified
15 17.980 473,2328 473,2328 ___ C30H34O5 6.1 Not identified
The compounds were tentatively identified according to mass spectra and corresponding literature data. Peak no: Peak number, Rt min: Retention time in minutes, [MH] -
Observed: Mass observed in experiment, [MH] - Calculated: Mass calculated by software, Product Ions: Ionic product, Ppm:, Putative name : Possible name.
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Table 3 shows the IC50 of the Flavonoid and Tannic Fractions from
fresh P. guajava L. leaves tested in isolation and in combination with
each other, in addition to the effect of Fluconazole as the antifungal
control against different Candida species. Values ranged from 102.2
to 1130.37mg/mL. The Flavonoid fraction showed activity against the
three strains tested however at concentrations higher than the Flu-
conazole control, with the lowest value being obtained for CA 40,006
with an IC50 of 744.30mg/mL.
The isolated tannic fraction showed a significant inhibition against
the first two strains tested, an action even better than the control,
obtaining the lowest value of the assay with an IC50 of 105.10 mg/mL
for CA 40,006, evidencing its inhibitory potential. The association of
the fractions was less effective than the isolated tannic fraction
against CA and CT, suggesting an antagonism, however the concen-
tration values were smaller than the systemic antifungal and showed
a synergism with the lowest value of 102.2 mg/mL for CK 40,095, in
relation to the isolated tannic fraction.
Whilst analyzing the cell viability curve of the fungi in relation to
the fractions and FCZ in their different concentrations (Fig. 1.a)
against CA 40,006, it can be seen that the isolated flavonoid fraction
showed an elevation of its concentration alone, this being a statisti-
cally relevant fact against fluconazole at concentrations between 16
to 512mg/mL.
The tannic fraction initially did not demonstrate an effective
action against CA 40,006 at concentrations between 16 and 32 mg/
mL (Fig. 1.a), however with the increase in concentration there wasTable 3
IC50 (mg/mL) of the Flavonoid and Tannic Fractions of Fresh Leaves of P. gua-
java against Candida strains.
Strains FCZ FFFLPG TTFFLPG FFFLPG + TFFLPG
CA INCQS 40,006 378.8 744.3 105.1 241.8
CT INCQS 40,042 925.56 1130.37 236.4 481.9
CK INCQS 40,095 163 599 385.9 102.2
FCZ: Fluconazole, FFFLPG: Flavonoid Fraction of Fresh Leaves of Psidium gua-
java, TFFLPG: Tannic Fraction Fresh Leaves of Psidium guajava; CA: Candida
albicans; CT: Candida tropicalis; CK: Candida krusei; INCQS: National Institute
of Quality Control in Health.an improvement in its inhibition potential at concentrations from
128 to 1024 mg/ml. Regarding the association observed, they acted
synergistically at concentrations from 512 and 1024mg/mL.
In Fig. 1.b, the action of the compounds against CT 40,042 are
shown, it can be seen that the FFDLPG fraction alone did not demon-
strate a positive inhibitory effect, as it acted antagonistically to the
control at concentrations from 1024 and 2048 mg/mL. TFDLPG
showed a significant inhibition at concentrations from 256 to
1024 mg/mL, being more effective than fluconazole. The fractions
together had a synergistic action at concentrations from 256 to
1024mg/mL.
The action of the compounds against CK 40,095 can be seen in
Fig. 1.c where it is possible to notice similar results. FFDLPG again
showed weak inhibitory activity with antagonism in concentrations
from 256 to 1024 mg/mL. TFDLPG showed an inverse action in rela-
tion to FCZ at the concentration of 256 mg/mL, however the associa-
tion of the fractions obtained a significant activity at the
concentration of 128 mg/mL, being statistically relevant in relation to
Fluconazole, reaching total growth inhibition at 512 mg/mL, a clini-
cally relevant value for a future drug as an alternative therapy for the
treatment of fungal infections.
3.3. Effect of the association of the individual fractions, associated with
each other in combination with Fluconazole: growth inhibition - Cell
viability curve and IC50
In Table 4 and Fig. 2 we can observe the activity of the fractions in
conjunction with the antifungal FCZ, through the IC50 and the cell via-
bility curve of the Flavonoid and Tannic Fractions from Fresh P. gua-
java L. Leaves tested in combination with Fluconazole against
Candida spp. to analyze if these can potentiate the action of the drug.
Values ranged from 1.38 to 925.56 mg/mL. FFFLPG + FCZ expressed a
synergistic effect with a significant reduction in concentration in all
tested strains compared to the control.
The lowest value of the natural product was 4.78 mg/mL against
CA. In relation to the TFFLPG + FCZ, in this test this union of substan-
ces was the one that exhibited a remarkable result, with a synergistic
effect against all lineages, since the concentrations were reduced
notably, with the smaller value of the test found against CK with an
IC50 of 1.38 mg/mL. Another fact that is evidenced are the concentra-
tion values of the Tannic fraction + FCZ against CA and CT in compari-
son with the isolated FCZ where, respectively, they reduced the
Table 4
IC50 (mg/mL) of the Flavonoid and Tannic Fractions of Fresh Leaves of Psidium guajava in association with
Fluconazole against Candida strains.
Strains FLUCONAZOLE (FCZ) FFFLPG + FCZ TTFFLPG + FCZ FFFLPG + TFFLPG + FCZ
CA INCQS 40,006 378.8 4.787 2.16 3.65
CT INCQS 40,042 925.56 16.050 2.17 22.95
CK INCQS 40,095 163 19.120 1.38 96.56
FCZ: Fluconazole, FFFLPG: Flavonoid Fraction of Fresh Leaves of Psidium guajava, TFFLPG: Tannic Fraction
Fresh Leaves of Psidium guajava; CA: Candida albicans; CT: Candida tropicalis; CK: Candida krusei; INCQS:
National Institute of Quality Control in Health.
Fig. 1. Antifungal effect of Flavonoid and Tannic Fractions fresh leaves of P. guajava individual and associated with each other and Fluconazole as a control against Candida strains.
FCZ: Fluconazole, FFLPG: Flavonoid Fraction of Fresh Leaves of Psidium guajava, TFFLPG: Tannic Fraction Fresh Leaves of Psidium guajava; CA: Candida albicans; CT: Candida tropicalis;
CK: Candida krusei; INCQS: National Institute of Quality Control in Health.
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association of the test. From the test a relevant factor in relation to
the possible decrease in drug toxicity and reduction of side effects
commonly caused by systemic antifungals.
The FFFLPG + TFFLPG + FCZ presented a result with similarities to
the previous ones, with synergism in all strains tested as can be
observed in Table 4. Analyzing the curves of cellular viability featured
in the Figs. 2.a and 2.b, they show the action of the compounds com-
bined with Fluconazole confronting to CA 40006and CT 40,042, in
which it was obtained similar effects, in this figures every compound
prove themselves more efficiently than the isolated FCZ, the FFFLPG
has shown a strong synergism in the concentration amounts of 8 to
1024 mg/mL for CA, and 16 to 1024 mg/mL for CT, both in statistically
significant rates.
The fraction TFFLPG associated with FCZ was the substance that
has shown the most obvious antifungal potential among the three
lineages, it acted synergically, showing a intense effect of inhibition,
featured in the Fig. 2.c, in which it practically decreased the overall
growth in the concentration amount of 2 mg/mL. Analyzing the asso-
ciation of fractions and the FCZ, it was obtained considerable rates,
given that it was it was observed the total inhibition of the fungicalgrowth in the concentration of 32, 64 and 256 mg/mL, respectively,
important rates, considering the fact that an inhibition  500 mg/mL
are clinically relevant (Rosas et al., 2007).
3.4. Minimum Fungicide concentration: evaluation of the association of
individual fractions, associated with each other and in combination with
Fluconazole: fungicidal or fungistatic effect
The concentration (MFC) was determined according to the
method used by Ernst et al. (1999). The results the MFC of the frac-
tions was considered the concentration that caused the absence of
colony growth (Ernst et al., 1999). The values ranged from 512 to 
4096 mg/mL, to begin with we evaluated the fractions in their intrin-
sic activity, where they presented a fungistatic effect, since they
reduced the yeast population in the test. The concentration values
were similar in all the tested strains, with the exception of the associ-
ation of the fractions with the C. krusei strain which showed fungi-
cidal activity at the 1024mg/mL concentration.
The association of the fractions with Fluconazole, with the con-
centrations that stood out being against the CK 40,095 strain, since
they presented fungicidal effect with values of 512 mg/mL for the
Fig. 2. Antifungal effect of Flavonoid and Tannic Fractions fresh leaves of P. guajava individual and associated with each other and Fluconazole as a control against Candida.
FCZ: Fluconazole, FFLPG: Flavonoid Fraction of Fresh Leaves of Psidium guajava, TFFLPG: Tannic Fraction Fresh Leaves of Psidium guajava; CA: Candida albicans; CT: Candida tropi-
calis; CK: Candida krusei; INCQS: National Institute of Quality Control in Health.
C.F. Bezerra et al. / South African Journal of Botany 131 (2020) 421427 425isolated fractions associated to FCZ and 1024 mg/mL for the fractions
associated with each other and with FCZ, knowing that FCZ is a fungi-
static antifungal, which when associated an increased efficacy possi-
bly occurred, promoting a fungicidal action against this strain
resistant to the drug in question.3.5. Fraction activity on fungal morphology: virulence control
In the micromorphological test, three concentrations 512 (HCA/4),
2048 (HCA) and 4096 (HCA x2) mg/mL were used, where the latter
two showed that they were able to alter the phenotypic transition of
C. albicans, C. krusei and C. tropicalis reducing and even totally inhibit-
ing the manifestation of filamentous structures that act as mecha-
nisms of fungal virulence.
Hyphae formation was generally prevented from the second con-
centration tested. At a lower concentration the fraction (FFFLPG) did
not reveal an effective activity on the inhibition of the filaments, as it
is possible to observe (supplementary material) the extension and
the formation of filamentous structures in the three strains tested,
however, at higher concentrations (2048 and 4096 mg/mL) the
dimorphism and propagation of hyphae for CA and CT was markedly
inhibited. For CK however, only at the HCA x2 concentration was the
FFFLPG able to inhibit the pleomorphism process.
The action of TFFLPG on morphology demonstrated a more signifi-
cant potential than the previous one, since it was able to completely
inhibit the manifestation of filamentous structures against C. albicans
at its lowest concentration (HCA/4 - 512 mg/mL). In contrast, against
C. tropicalis, it was possible to detect hyphae at the lowest concentra-
tion, however, at consecutive concentrations the inactivation of these
hyphae was observed. In relation to C. krusei, an inhibition can onlybe evidenced at the concentration of 4096 mg/mL, with 100% of
hyphal regression.
The associated fractions acting on the morphology of the strains
showed at the lowest concentration (512 mg/mL) the associated frac-
tions were not powerful enough to alter the virulence mechanism of
the strains, however they inhibited the propagation and fungal
growth of hyphae satisfactorily from the second tested concentration
of 2048 mg/mL against CA and CT, however the CK yeast presented
total inhibition only at the concentration of 4096mg/mL.
In the supplementary material of this article the photographs of
micromorphology can be observed with the inhibition of the filamen-
tous structures.4. Discussion
The compounds Myricetin, catechin, gallic acid, ellagic and its
derivatives (Chang et al., 2013), catechin, epicatechin, rutin, naringe-
nin and kaempferol (Chen et al., 2010), other flavonoids, such as nar-
ingenin, flavones and flavanols, including kaemferol, morin and
quercetin, are part of an extensive group of secondary plant metabo-
lites that have been described as having antimicrobial activities
(Rauha et al., 2000), corroborating with our study where we also find
some of these compounds as can be seen in Tables 1 and 2.
One of the most numerous and representative groups of bioactive
substances are the phenolic compounds that are present in a large
part of fruits and vegetables used for the consumption of the popula-
tion (Soto-Vaca, 2012). In the study by Scherer & Godoy (2014) when
evaluating solvent extractions of different polarities, ethyl acetate
and chloroform/dichloromethane solvents (1:1) showed lower
extraction capacity of phenolic compounds, with lowest values for all
426 C.F. Bezerra et al. / South African Journal of Botany 131 (2020) 421427compounds, which may be associated with a lower solubility of phe-
nolic compounds in low polarity solvents.
In addition, in their work, other substances from other classes, dif-
ferent from the expected phenolic compounds, were identified by the
LC-ESI-MS-MS-TOF method, a similar method to ours, whose study
corroborates with our study, since the extractors used selected, in
general, phenolic compounds thus being possible to find them in
both fractions in the present study.
Flores et al. (2013) in their study with fractions from the species
Psidium friedrichsthalianum was able to identify components such as
ellagic acid, myricetin, quercitrin and quercetin, respectively. P. gua-
java is mainly known for its medicinal antispasmodic and antimicro-
bial activities in the treatment of enteritis, and may also demonstrate
other bioactivities (Gutierrez, Mitchell e Solis, 2008).
In Brazil P. guajava is commonly used for the treatment of oral dis-
eases, where the leaves as well as the peels are used in the prepara-
tion of teas to be swallowed or mashed whilst still hot, with
pretensions to fight thrush, which can be caused by Candida strains
(Oliveira et al., 2010).
In addition, there are records that various parts of the plant are
used not only to treat candidiasis, but also to treat leukorrhea (Fenner
et al., 2006), one of the symptoms of vaginal candidiasis. In South
Africa, guava leaf and root tea are prepared for the treatment of non-
specific sexually transmitted diseases (Van Vuuren & Naidoo, 2010).
This species can also be found in national lists of medicinal plants
in some countries and is used in public policy programs aimed at pri-
mary health care, as occurs for example in Brazil (RENISUS, 2009).
Morais-Braga et al. (2015) evaluated the action of P. guajava
extracts against C. albicans and C. tropicalis having as a result the MIC
of the products in this study determined as 8192 mg/mL in which a
marked reduction in the percentage of viable microorganisms was
observed. The results of the Minimum Fungicide Concentration
showed that, at the concentrations tested, no extract showed a
fungicidal effect. In this case, the antifungal effect observed was
fungistatic, since the Minimum Fungicide Concentration was >
8192 mg/mL.
In order to evaluate the modifying effect of aqueous and hydroe-
thanolic extracts from plants of the Psidium genus, among them P.
guajava, in association with Fluconazole, against C. albicans and C. tro-
picalis, Morais-Braga et al. (2016) obtained synergistic relationships
in both extracts, corroborating this study.
Some phenolic compounds such as gallic acid, catechin, luteolin
and quercetin have demonstrated in vitro antifungal potential against
different Candida species, including C. albicans and C. tropicalis (Alves
et al., 2014). Bisignano et al. (2000) refuted the antifungal activity
against Candida albicans for the compounds gallic acid, kaempferol
and rutin, with the best effect being exerted by gallic acid.
Morais-Braga et al. (2015) in their study evaluated the action of
aqueous and hydroalcoholic extracts from P. guajava L. leaves
against C. albicans and C. tropicalis strains and while carrying out
the test found the IC50 of the extracts ranging from 1803.02 to
5623.41 mg/mL, with the value found being higher than the pres-
ent study. However, it is worth mentioning that the present work
used different extractive solvents, these being more specific and
suitable for the prospection of flavonoids and tannins, therefore
the results would probably be differentiated as well.
With regard to MFC in another study with extracts from P. guajava
L. leaves, a fungistatic effect (> 8192 mg/mL) was observed in the
MFC assay, since it reduced the number of Candida colonies (Morais-
Braga et al., 2015).
One of the most important mechanisms of Candida virulence is
cell dimorphism. This dimorphic state can be defined as the ability to
change the cell morphology, reversibly, varying from the yeast or
hyphal form. This is due to the ejection of a filamentous structure,
becoming dispersive to invasive, respectively, characterizing a pro-
cess commonly seen in systemic candidemia (Lu et al., 2014).Changes in fungal morphology, from the activity of P. guajava extracts
were reported by Morais-Braga et al. (2015) at concentrations of 4096,
8192 and 16,384 mg/mL which showed that they were able to alter C.
albicans and C. tropicalis dimorphism, decreasing filamentous structures
as concentrationswere increased, a similar effect to our study.
Conclusion
The flavonoid and tannic fractions from fresh P. guajava leaves had
in this study their potential revealed from the experiments made. The
fractions presented in their composition phenolic compounds with
antifungal effect previously evidenced that may have contributed to
the synergic effect of the tests. Being true active antifungal agents,
they inhibited the growth of Candida spp. colonies in isolated use,
however, they obtained better activity in conjunction with the drug,
since they potentiated the action of the systemic antifungal reference
(Fluconazol), reducing its concentration and increasing its effective-
ness, whilst regressing and affecting an important factor of fungal vir-
ulence, which is a morphological transition through the emission of
hyphae. The tannic fraction was evidenced with the best results from
the assays, with a more significant performance in the assays in asso-
ciation with the reference antifungal. These results show that these
fractions have active antifungal constituents, however, more in-
depth studies are needed to prove their effectiveness and safety. In
fact, these results make this natural product a strong candidate for a
new drug or an adjuvant for the treatment of fungal diseases. Further
studies using animal models are required to verify the in vivo efficacy
of these.
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